Responses
Parallel Session B: Thursday 12 September 2013
Cardiovascular diseases
OP25 Benefits and Risks from Aspirin use in the Primary Prevention of Cardiovascular Disease and Cancer: A Systematic Review and Overview of Reviews of Randomised Trial Evidence
Compose a Response to This Article
Other responses
No responses have been published for this article.